MY148945A - Combination of a betamimetic with anticholinergics and/or steroids - Google Patents

Combination of a betamimetic with anticholinergics and/or steroids

Info

Publication number
MY148945A
MY148945A MYPI20051739A MYPI20051739A MY148945A MY 148945 A MY148945 A MY 148945A MY PI20051739 A MYPI20051739 A MY PI20051739A MY PI20051739 A MYPI20051739 A MY PI20051739A MY 148945 A MY148945 A MY 148945A
Authority
MY
Malaysia
Prior art keywords
betamimetic
anticholinergics
steroids
combination
preparing
Prior art date
Application number
MYPI20051739A
Inventor
Ingo Konetzki
Thierry Bouyssou
Philipp Lustenberger
Michael P Pieper
Andreas Schnapp
Christoph Hoenke
Sabine Pestel
Klaus Rudolf
Michel Pairet
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY148945(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/en
Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MY148945A publication Critical patent/MY148945A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

THE PRESENT INVENTION RELATES TO NEW MEDICAMENT COMBINATIONS WHICH CONTAIN IN ADDITION TO ONE OR MORE, PREFERABLY ONE, COMPOUND OF GENERAL FORMULA 1, WHEREIN THE GROUPS R¹, R², AND R³ MAY HAVE THE MEANING GIVEN IN THE CLAIMS AND IN THE SPECIFICATION, AT LEAST ONE OTHER ACTIVE SUBSTANCE 2, PROCESSES FOR PREPARING THEM AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS.
MYPI20051739A 2004-04-22 2005-04-20 Combination of a betamimetic with anticholinergics and/or steroids MY148945A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004019540A DE102004019540A1 (en) 2004-04-22 2004-04-22 Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives
DE102004052987A DE102004052987A1 (en) 2004-11-03 2004-11-03 Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives
EP05002496 2005-02-07

Publications (1)

Publication Number Publication Date
MY148945A true MY148945A (en) 2013-06-14

Family

ID=34966478

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20051739A MY148945A (en) 2004-04-22 2005-04-20 Combination of a betamimetic with anticholinergics and/or steroids

Country Status (33)

Country Link
EP (2) EP1781298B1 (en)
JP (1) JP2007533683A (en)
KR (2) KR20130049840A (en)
AR (1) AR049262A1 (en)
AT (1) ATE539754T1 (en)
AU (1) AU2005235419B2 (en)
BE (1) BE2015C065I2 (en)
BR (1) BRPI0510080B8 (en)
CA (1) CA2559699C (en)
CY (3) CY1113890T1 (en)
DK (2) DK2422786T3 (en)
EA (1) EA013157B1 (en)
EC (1) ECSP066947A (en)
ES (2) ES2523518T3 (en)
FI (1) FIC20170005I1 (en)
FR (1) FR16C0029I2 (en)
HU (1) HUS1500058I1 (en)
IL (2) IL177685A (en)
LT (1) LTC1781298I2 (en)
LU (1) LU93066I2 (en)
MY (1) MY148945A (en)
NL (1) NL300779I2 (en)
NO (2) NO337714B1 (en)
NZ (1) NZ550797A (en)
PE (1) PE20060462A1 (en)
PL (2) PL1781298T4 (en)
PT (2) PT2422786E (en)
SG (1) SG152237A1 (en)
SI (2) SI2422786T1 (en)
TW (2) TWI374739B (en)
UY (1) UY28861A1 (en)
WO (1) WO2005102349A1 (en)
ZA (1) ZA200606624B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (en) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for the inhalation of beta agonists
US7923455B2 (en) * 2005-01-28 2011-04-12 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
EP1855689A1 (en) * 2005-02-16 2007-11-21 Boehringer Ingelheim International GmbH Pharmaceutical compositions comprising anticholinergics and etiprednol
KR101360803B1 (en) 2005-08-15 2014-02-11 베링거 인겔하임 인터내셔날 게엠베하 Method for producing betamimetics
US20070088030A1 (en) * 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
TWI396541B (en) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int Novel combinations of medicaments for the treatment of respiratory diseases
WO2007058971A2 (en) 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic esters
EP1986644A1 (en) * 2006-02-16 2008-11-05 Boehringer Ingelheim International GmbH Drug combinations for the treatment of respiratory tract diseases
US20090324510A1 (en) 2006-08-07 2009-12-31 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
UY30543A1 (en) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int AEROSOL FORMULATION FOR INHALATION OF BETA- AGONISTS
UY30542A1 (en) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS
EP2086641A2 (en) * 2006-10-26 2009-08-12 Boehringer Ingelheim International GmbH Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
EP1921070A1 (en) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
US8497369B2 (en) 2008-02-07 2013-07-30 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production
EP2313397B1 (en) 2008-08-08 2016-04-20 Boehringer Ingelheim International GmbH Cyclohexyloxy substituted heterocycles, medicine containing these connections, their application and production method
WO2010060875A1 (en) * 2008-11-27 2010-06-03 Boehringer Ingelheim International Gmbh Novel powdered crystalline medicines for inhalation
WO2014016548A2 (en) 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
EP0211595B1 (en) 1985-07-30 1991-11-13 Glaxo Group Limited Devices for administering medicaments to patients
SE453566B (en) 1986-03-07 1988-02-15 Draco Ab POWDER INHALATOR DEVICE
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (en) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Capsule holder
DE19536902A1 (en) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Miniature fluid pressure generating device
AU5629301A (en) 2000-04-27 2001-11-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel, slow-acting betamimetics, a method for their production and their use as medicaments
DE50103666D1 (en) 2000-10-12 2004-10-21 Boehringer Ingelheim Pharma CRYSTALLINE MONOHYDRATE OF TIOTROPIUM BROMIDE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN THE PRODUCTION OF A MEDICAMENT
PL208137B1 (en) 2001-06-22 2011-03-31 Boehringer Ingelheim Pharma Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
DE10130371A1 (en) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics, corticosteroids and betamimetics
ES2203327B1 (en) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. NEW QUINUCLIDINE CARBAMATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE10230751A1 (en) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on new anticholinergics and EGFR kinase inhibitors
DE10246374A1 (en) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg New 4-(2-alkylamino-1-hydroxyethyl)-3-alkoxy-benzene-1,2-diol derivatives, are beta-mimetics having a long duration of action, useful e.g. for treating asthma, chronic obstructive pulmonary disease or arrhythmia
DE10253282A1 (en) 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration

Also Published As

Publication number Publication date
SG152237A1 (en) 2009-05-29
IL177685A (en) 2013-10-31
JP2007533683A (en) 2007-11-22
FR16C0029I1 (en) 2016-08-26
ES2523518T3 (en) 2014-11-26
PE20060462A1 (en) 2006-06-19
KR20130049840A (en) 2013-05-14
EP2422786B1 (en) 2014-08-13
CY2017014I2 (en) 2017-11-14
FIC20170005I1 (en) 2017-01-13
PT1781298E (en) 2012-02-03
ES2380370T3 (en) 2012-05-11
IL226562A0 (en) 2013-06-27
CA2559699C (en) 2012-06-19
KR20070015592A (en) 2007-02-05
ATE539754T1 (en) 2012-01-15
HUS1500058I1 (en) 2016-01-28
PT2422786E (en) 2014-11-12
AU2005235419B2 (en) 2010-11-04
UY28861A1 (en) 2005-11-30
NO2016022I1 (en) 2016-12-01
IL177685A0 (en) 2006-12-31
CA2559699A1 (en) 2005-11-03
AU2005235419A1 (en) 2005-11-03
BE2015C065I2 (en) 2024-08-08
DK2422786T3 (en) 2014-11-17
NO20065060L (en) 2006-11-21
BRPI0510080B8 (en) 2021-05-25
CY1113890T1 (en) 2016-07-27
ZA200606624B (en) 2008-01-08
SI2422786T1 (en) 2014-12-31
EA200601846A1 (en) 2007-04-27
EP1781298A1 (en) 2007-05-09
BRPI0510080A (en) 2007-10-16
FR16C0029I2 (en) 2017-01-27
SI1781298T1 (en) 2012-04-30
PL1781298T3 (en) 2012-06-29
WO2005102349A1 (en) 2005-11-03
AR049262A1 (en) 2006-07-12
TWI374739B (en) 2012-10-21
TWI372056B (en) 2012-09-11
NL300779I2 (en) 2017-11-02
CY1115719T1 (en) 2017-01-25
CY2017014I1 (en) 2017-11-14
BRPI0510080B1 (en) 2020-08-18
LTC1781298I2 (en) 2018-09-25
PL1781298T4 (en) 2017-07-31
EP2422786A1 (en) 2012-02-29
PL2422786T3 (en) 2015-02-27
NO337714B1 (en) 2016-06-06
ECSP066947A (en) 2007-01-26
NZ550797A (en) 2010-08-27
EA013157B1 (en) 2010-02-26
EP1781298B1 (en) 2012-01-04
KR101287460B1 (en) 2013-07-23
NO2016022I2 (en) 2016-12-01
DK1781298T3 (en) 2012-05-07
LU93066I2 (en) 2016-07-11
TW201231055A (en) 2012-08-01

Similar Documents

Publication Publication Date Title
TW200801003A (en) Novel compounds
TW200800999A (en) Novel compounds
WO2005055983A3 (en) Method of preparation of mixed phase co-crystals with active agents
WO2008121348A3 (en) Peripheral opioid receptor antagonists and uses thereof
EA201000436A1 (en) STEROID [3,2-С] PYRAZOLIC COMPOUNDS WITH GLUCOCORTICOID ACTIVITY
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
TW200716628A (en) Novel compounds
EP2279732A3 (en) Compounds and compositions for delivering active agents
SE0302139D0 (en) Novel compounds
ZA200809714B (en) Synergistic active ingredient combinations
SE0402925D0 (en) Novel Compounds
TW200730178A (en) Aerosol formulations for the inhalation of β-agonists
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
TW200639156A (en) New compounds
SE0401763D0 (en) Compounds
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
WO2010054606A3 (en) Triperpenoid 2 - deoxy glycosides and use thereof as medicaments
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
TW200800993A (en) Organic compounds
WO2008023003A8 (en) Drug combinations for treating airway diseases
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
MY148403A (en) Aerosol formulation for the inhalation of beta-agonists
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
WO2006128847A3 (en) Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient